Literature DB >> 2204816

The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain.

P Bull1, K L Morley, M F Hoekstra, T Hunter, I M Verma.   

Abstract

We have shown that the murine c-rel protein can act as a transcriptional transactivator in both yeast and mammalian cells. Fusion proteins generated by linking rel sequences to the DNA-binding domain of the yeast transcriptional activator GAL4 activate transcription from a reporter gene linked in cis to a GAL4 binding site. The full-length mouse c-rel protein (588 amino acids long) is a poor transactivator; however, the C-terminal portion of the protein between amino acid residues 403 to 568 is a potent transcriptional transactivator. Deletion of the N-terminal half of the c-rel protein augments its transactivation function. We propose that c-rel protein has an N-terminal regulatory domain and a C-terminal transactivation domain which together modulate its function as a transcriptional transactivator.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2204816      PMCID: PMC361256          DOI: 10.1128/mcb.10.10.5473-5485.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

Review 1.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

2.  Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb.

Authors:  K Weston; J M Bishop
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

3.  Structure of a mammalian c-rel protein deduced from the nucleotide sequence of murine cDNA clones.

Authors:  R J Grumont; S Gerondakis
Journal:  Oncogene Res       Date:  1989

4.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

5.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

Review 6.  Fos and Jun: the AP-1 connection.

Authors:  T Curran; B R Franza
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

7.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

Authors:  P Angel; K Hattori; T Smeal; M Karin
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

8.  p59v-rel, the transforming protein of reticuloendotheliosis virus, is complexed with at least four other proteins in transformed chicken lymphoid cells.

Authors:  S Simek; N R Rice
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

9.  Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation.

Authors:  W W Lamph; V J Dwarki; R Ofir; M Montminy; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

10.  Induction of proto-oncogene JUN/AP-1 by serum and TPA.

Authors:  W W Lamph; P Wamsley; P Sassone-Corsi; I M Verma
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

View more
  63 in total

1.  The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.

Authors:  W H Walker; B Stein; P A Ganchi; J A Hoffman; P A Kaufman; D W Ballard; M Hannink; W C Greene
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  c-rel activates but v-rel suppresses transcription from kappa B sites.

Authors:  J Inoue; L D Kerr; L J Ransone; E Bengal; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains.

Authors:  P J Morin; T D Gilmore
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

4.  Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation.

Authors:  Brendan A Hilliard; Nicola Mason; Lingyun Xu; Jing Sun; Salah-Eddine Lamhamedi-Cherradi; Hsiou-Chi Liou; Christopher Hunter; Youhai H Chen
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

5.  Alternate RNA splicing of murine nfkb1 generates a nuclear isoform of the p50 precursor NF-kappa B1 that can function as a transactivator of NF-kappa B-regulated transcription.

Authors:  R J Grumont; J Fecondo; S Gerondakis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities.

Authors:  R J Grumont; S Gerondakis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B.

Authors:  J R Matthews; W Kaszubska; G Turcatti; T N Wells; R T Hay
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

8.  The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.

Authors:  X Liu; C W Miller; P H Koeffler; A J Berk
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element.

Authors:  A Sica; T H Tan; N Rice; M Kretzschmar; P Ghosh; H A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

10.  Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation.

Authors:  N D Perkins; R M Schmid; C S Duckett; K Leung; N R Rice; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.